Clinical Trial

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

Study acronym: ID-ENTITY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the association between time-updated CMV and BK viral loads measured monthly by T-ID and the risk of CMV disease and/or biopsy-proven BK virus-associated nephropathy (BKVAN) during the first 12 months following kidney transplantation, accounting for the net immune environment (TTV viral load) and allograft injury (donor-derived cell-free DNA, dd-cfDNA).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-30.
Trial Details
NCT Number NCT07393594
Lead Sponsor Transplant Genomics, Inc.
Conditions Kidney Diseases, Kidney Injury, BK Virus Infection, CMV, TTV Virus
Enrollment 1,000 participants
Start Date 2026-03-31
Primary Completion 2028-04-30 (estimated)
Study Completion 2028-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-24